Search
Codexis Inc
CDXSAdd to Watchlist
2.460USD
-0.110-4.28%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
223.61MMarket Cap
LossP/E TTM
More Details of Codexis Inc Company
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Codexis Inc Info
Ticker SymbolCDXS
Company nameCodexis Inc
IPO dateApr 22, 2010
CEOMoore (Alison)
Number of employees188
Security typeOrdinary Share
Fiscal year-endApr 22
Address200 Penobscot Dr
CityREDWOOD CITY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94063
Phone16504218100
Websitehttps://www.codexis.com/
Ticker SymbolCDXS
IPO dateApr 22, 2010
CEOMoore (Alison)
Company Executives of Codexis Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
--
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
87.42K
--
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
--
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
66.81K
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
America
43.54M
61.85%
China
9.30M
13.21%
India
5.70M
8.10%
EMEA
4.39M
6.24%
Switzerland
4.20M
5.97%
Other
3.26M
4.63%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
abrdn Inc.
9.55%
Opaleye Management Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
6.72%
Millennium Management LLC
5.21%
Lytton (Laurence W)
4.99%
Other
66.07%
Shareholders
Shareholders
Proportion
abrdn Inc.
9.55%
Opaleye Management Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
6.72%
Millennium Management LLC
5.21%
Lytton (Laurence W)
4.99%
Other
66.07%
Shareholder Types
Shareholders
Proportion
Investment Advisor
26.66%
Investment Advisor/Hedge Fund
25.52%
Hedge Fund
20.76%
Individual Investor
7.41%
Research Firm
1.58%
Pension Fund
0.18%
Bank and Trust
0.16%
Venture Capital
0.08%
Other
17.65%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
273
66.34M
73.00%
-13.88M
2025Q4
259
63.79M
84.44%
-3.19M
2025Q3
270
67.24M
85.39%
-6.33M
2025Q2
272
73.50M
96.12%
+3.66M
2025Q1
304
67.35M
93.04%
-9.72M
2024Q4
323
66.35M
93.32%
+1.38M
2024Q3
331
65.10M
96.64%
+10.35M
2024Q2
345
54.66M
101.93%
-1.25M
2024Q1
358
56.38M
110.38%
-21.50M
2023Q4
374
58.04M
110.76%
+374.07K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
abrdn Inc.
7.97M
8.77%
+3.87M
+94.68%
Dec 31, 2025
Opaleye Management Inc.
6.79M
7.47%
-4.94M
-42.13%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.11M
6.72%
+236.37K
+4.02%
Dec 31, 2025
Millennium Management LLC
3.14M
3.45%
-932.37K
-22.92%
Dec 31, 2025
Lytton (Laurence W)
4.53M
4.99%
+4.53M
--
Mar 06, 2026
Nantahala Capital Management, LLC
3.99M
4.39%
-40.45K
-1.00%
Dec 31, 2025
Telemark Asset Management, LLC
3.85M
4.23%
-153.59K
-3.84%
Dec 31, 2025
Columbia Threadneedle Investments (US)
3.79M
4.17%
+1.02M
+36.77%
Dec 31, 2025
UBS Financial Services, Inc.
809.52K
0.89%
+287.14K
+54.97%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.47%
iShares Micro-Cap ETF
0.04%
Invesco Nasdaq Biotechnology ETF
0.02%
Fidelity Enhanced Small Cap ETF
0.02%
iShares Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
Global X Russell 2000 ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.47%
iShares Micro-Cap ETF
Proportion0.04%
Invesco Nasdaq Biotechnology ETF
Proportion0.02%
Fidelity Enhanced Small Cap ETF
Proportion0.02%
iShares Biotechnology ETF
Proportion0.02%
ProShares Ultra Nasdaq Biotechnology
Proportion0.02%
Global X Russell 2000 ETF
Proportion0.01%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
